K-ras Mutations in Non-Small-Cell Lung Carcinoma: A Review
作者： Sarit Aviel-Ronen , Fiona H. Blackhall , Frances A. Shepherd , Ming-Sound Tsao
关键词: Signal transduction 、 Mutation 、 Lung cancer 、 Immunology 、 Molecular pathology 、 Malignancy 、 Carcinoma 、 Biomarker (cell) 、 Medicine 、 Radiation therapy 、 Cancer research
摘要: … K-ras mutations will be the focus of this review because they are the most linked to non–small-cell lung cancer (… rate, the shift of histologic subtype from squamous cell carcinoma to …
manchester.ac.uk参考文章(89)
Thomas K Schlesinger, Gary R Fanger, Toshi Yujiri, Gary L Johnson, The TAO of MEKK Frontiers in Bioscience. ,vol. 3, pp. d1181- 1186 ,(1998) , 10.2741/A354
Reinhard Dammann, Chun Li, Jung-Hoon Yoon, Philip L. Chin, Steven Bates, Gerd P. Pfeifer, Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nature Genetics. ,vol. 25, pp. 315- 319 ,(2000) , 10.1038/77083
Leisa Johnson, Kim Mercer, Doron Greenbaum, Roderick T. Bronson, Denise Crowley, David A. Tuveson, Tyler Jacks, Somatic activation of the K-ras oncogene causes early onset lung cancer in mice Nature. ,vol. 410, pp. 1111- 1116 ,(2001) , 10.1038/35074129
Kirsti Husgafvel-Pursiainen, Antti Karjalainen, Annamaria Kannio, Sisko Anttila, Timo Partanen, Anneli Ojajärvi, Harri Vainio, Lung cancer and past occupational exposure to asbestos. Role of p53 and K-ras mutations. American Journal of Respiratory Cell and Molecular Biology. ,vol. 20, pp. 667- 674 ,(1999) , 10.1165/AJRCMB.20.4.3404
S Rodenhuis, L Boerrigter, B Top, R J Slebos, W J Mooi, L van't Veer, N van Zandwijk, Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study. Journal of Clinical Oncology. ,vol. 15, pp. 285- 291 ,(1997) , 10.1200/JCO.1997.15.1.285
Joan H. Schiller, Sudeshna Adak, Richard H. Feins, Steven M. Keller, Willard A. Fry, Robert B. Livingston, M. Elizabeth M. Hammond, Barbara Wolf, Linda Sabatini, James Jett, Leslie Kohman, David H. Johnson, Lack of Prognostic Significance of p53 and K-ras Mutations in Primary Resected Non–Small-Cell Lung Cancer on E4592: A Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy Journal of Clinical Oncology. ,vol. 19, pp. 448- 457 ,(2001) , 10.1200/JCO.2001.19.2.448
Stephen L. Graziano, Gary P. Gamble, Nancy B. Newman, Lynn Z. Abbott, Michelle Rooney, Sulagna Mookherjee, Melissa L. Lamb, Leslie J. Kohman, Bernard J. Poiesz, Prognostic Significance of K-ras Codon 12 Mutations in Patients With Resected Stage I and II Non–Small-Cell Lung Cancer Journal of Clinical Oncology. ,vol. 17, pp. 668- 668 ,(1999) , 10.1200/JCO.1999.17.2.668
P Keohavong, J R Testa, J M Siegfried, A T Gillespie, J D Hunt, R Mera, T J Casey, Prognostic Value of Specific KRAS Mutations in Lung Adenocarcinomas Cancer Epidemiology, Biomarkers & Prevention. ,vol. 6, pp. 841- 847 ,(1997)
Julian R. Molina, Alex A. Adjei, The Ras/Raf/MAPK Pathway Journal of Thoracic Oncology. ,vol. 1, pp. 7- 9 ,(2006) , 10.1016/S1556-0864(15)31506-9
S. L. Zielinski, Press Release: Genetic Polymorphisms, Antidepressant Use May Be Associated With Altered Tamoxifen Activity JNCI Journal of the National Cancer Institute. ,vol. 97, pp. 1- 1 ,(2005) , 10.1093/JNCI/97.1.1-A